USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | 4500.00 | 10.25 Thousand | - |
Cost of Revenue | - | - | 300.00 | 2700.00 | 6150.00 | - |
Gross Profit | - | - | -300.00 | 1800.00 | 4100.00 | - |
Operating Expenses | - | - | 447.37 Thousand | 25.58 Thousand | 21.24 Thousand | 1181.00 |
Selling, General and Administrative Expenses | - | - | 447.37 Thousand | 25.58 Thousand | 21.24 Thousand | 1181.00 |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | 447.37 Thousand | 28.28 Thousand | 27.39 Thousand | 1181.00 |
Operating Income | - | - | -447.37 Thousand | -23.78 Thousand | -17.15 Thousand | -1181.00 |
Interest Expense | - | - | 131.22 Thousand | - | - | - |
Income Tax Expense | - | - | 131.22 Thousand | -5.00 | -171.61 Thousand | -1083.00 |
Earnings before Tax | - | - | -1.26 Million | -23.78 Thousand | -17.14 Thousand | -1181.00 |
Net Income | - | - | -1.39 Million | -23.78 Thousand | -17.14 Thousand | -1181.00 |
Earnings Per Share Basic | - | - | -0.02 | -0.00 | -0.00 | -0.00 |
Earnings Per Share Diluted | - | - | -0.02 | -0.00 | -0.00 | -0.00 |
Weighted Average Shares Outstanding | - | - | 68.25 Million | 69.56 Million | 51.92 Million | 3.29 Million |
Weighted Average Shares Outstanding (Diluted) | - | - | 68.25 Million | 69.56 Million | 51.92 Million | 3.29 Million |
Gross Margin | - | - | - | 0.40 | 0.40 | - |
EBIT Margin | - | - | - | -5.20 | -1.65 | - |
Profit Margin | - | - | - | -5.29 | -1.67 | - |
EBITDA | - | - | -447.07 Thousand | -23.38 Thousand | -16.89 Thousand | -1083.00 |
Earnings Before Tax Margin | - | - | - | -5.29 | -1.67 | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | - | - | - | - |
Operating Income | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - |
Earnings before Tax | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Earnings Per Share Basic | - | - | - | - | - | - |
Earnings Per Share Diluted | - | - | - | - | - | - |
Weighted Average Shares Outstanding | - | - | - | - | - | - |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | - | - |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - |
Earnings Before Tax Margin | - | - | - | - | - | - |
INPAP
IFT
300342
1030
IBX
EQ